ARKK - ETF AI Analysis
Top Page
Ark Innovation Etf (ARKK)
Rating:52Neutral
Price Target:―
Positive Factors
Focused Innovation Theme
The fund targets innovative companies in areas like health care and technology, which can benefit if disruptive businesses continue to grow over the long term.
Sector Diversification Within Growth Areas
Holdings are spread across several growth-oriented sectors such as health care, technology, consumer cyclical, and financials, helping reduce the impact if one innovative industry stumbles.
Strong Recent Performance From Select Holdings
Some top positions, such as Advanced Micro Devices and Twist Bioscience, have shown strong recent gains, which can help offset weaker names in the portfolio.
Negative Factors
High Expense Ratio
The fund charges a relatively high fee, which can eat into returns over time compared with lower-cost ETFs.
Concentrated Top Holdings
A small group of companies makes up a large share of the portfolio, increasing the risk that trouble in just a few stocks could significantly hurt the fund.
Recent Weak Performance and U.S. Concentration
The ETF has recently delivered weak returns and is heavily invested in U.S. companies, which increases exposure to both short-term volatility and the U.S. market specifically.
ARKK vs. SPDR S&P 500 ETF (SPY)
AUM6.30B
RegionGlobal
Expense Ratio0.75%
Beta2.05
IssuerARK
Inception DateOct 31, 2014
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume4,888,710
30 Day Avg. Volume6,392,808
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
107.58Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering45
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ARKK Summary
ARKK (Ark Innovation ETF) is an actively managed fund that focuses on “disruptive innovation” rather than a traditional stock index. It invests mainly in U.S. companies working on new technologies in areas like artificial intelligence, robotics, genetics, and digital finance. Well-known holdings include Tesla and AMD, along with firms such as Coinbase and Shopify. Someone might invest in ARKK if they want growth potential from cutting‑edge tech and a mix of different innovative companies in one fund. However, it can be very volatile and may rise or fall sharply because it is heavily concentrated in high‑risk technology and innovation stocks.
How much will it cost me?The Ark Innovation ETF (ARKK) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, meaning experts are constantly adjusting its holdings to focus on innovative and disruptive companies.
What would affect this ETF?The Ark Innovation ETF (ARKK) could benefit from continued advancements in technology and innovation, particularly in areas like artificial intelligence, robotics, and genomics, which are key focuses of its portfolio. However, it may face challenges from rising interest rates, which can negatively impact growth-focused investments, and regulatory changes in sectors like fintech or healthcare. Global economic uncertainty could also affect the performance of its top holdings, such as Tesla and Coinbase, which are sensitive to market conditions.
ARKK Top 10 Holdings
ARKK is leaning heavily into high-octane innovation, but its biggest bets have been a rough ride lately. Tesla sits at the top and is clearly losing steam, weighing on overall returns, while newer names like Tempus AI and SpaceX are also lagging, adding to the drag. Crypto-linked plays such as Coinbase and Circle have seen mixed momentum, keeping volatility high. On the brighter side, AMD and 10x Genomics are rising and helping to offset some of the pain. The fund is globally focused but thematically concentrated in cutting-edge tech and healthcare disruption.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Tesla | 9.16% | $576.59M | $1.30T | -2.40% | 73 Outperform | |
| SpaceX | 6.03% | $379.67M | $1.77T | ― | ― | |
| Tempus AI, Inc. Class A | 5.43% | $341.65M | $9.39B | -9.47% | 52 Neutral | |
| Shopify | 4.75% | $298.90M | $195.19B | 5.21% | ― | |
| Crispr Therapeutics AG | 4.67% | $293.98M | $5.17B | -3.43% | 40 Underperform | |
| Circle Internet Group, Inc. Class A | 4.26% | $268.09M | $16.89B | -58.40% | 64 Neutral | |
| Twist Bioscience | 4.04% | $254.04M | $7.25B | 351.97% | 43 Neutral | |
| Coinbase Global | 3.98% | $250.58M | $40.53B | -53.48% | 68 Neutral | |
| Palantir Technologies | 3.72% | $234.25M | $413.36B | -4.08% | 74 Outperform | |
| Robinhood | 3.51% | $221.10M | $83.88B | -16.81% | 68 Neutral |
ARKK Technical Analysis
Positive
―
Price Trends
77.52
Positive
76.24
Positive
76.82
Positive
Market Momentum
1.12
Negative
59.17
Neutral
90.09
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ARKK, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 76.09, equal to the 50-day MA of 77.52, and equal to the 200-day MA of 76.82, indicating a bullish trend. The MACD of 1.12 indicates Negative momentum. The RSI at 59.17 is Neutral, neither overbought nor oversold. The STOCH value of 90.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ARKK.
ARKK Peer Comparison
Comparison Results
Performance Comparison
ARKK
Ark Innovation Etf
82.59
5.58
7.25%
FWD
AB Disruptors ETF
―
―
―
ARKQ
ARK Autonomous Technology & Robotics ETF
―
―
―
CHAT
Roundhill Generative AI & Technology ETF
―
―
―
ARKG
ARK Genomic Revolution ETF
―
―
―
SQS
Sapient Quality Select ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents